194 related articles for article (PubMed ID: 23951051)
1. Epithelial V-like antigen mediates efficacy of anti-alpha₄ integrin treatment in a mouse model of multiple sclerosis.
Wright E; Rahgozar K; Hallworth N; Lanker S; Carrithers MD
PLoS One; 2013; 8(8):e70954. PubMed ID: 23951051
[TBL] [Abstract][Full Text] [Related]
2. Regulation of expansion of CD11c
Dungan M; Carrithers MD
Immunobiology; 2020 Mar; 225(2):151883. PubMed ID: 31818507
[TBL] [Abstract][Full Text] [Related]
3. α4-integrin deficiency in B cells does not affect disease in a T-cell-mediated EAE disease model.
Hussain RZ; Cravens PD; Miller-Little WA; Doelger R; Granados V; Herndon E; Okuda DT; Eagar TN; Stüve O
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e563. PubMed ID: 31086806
[TBL] [Abstract][Full Text] [Related]
4. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.
McArdel SL; Brown DR; Sobel RA; Sharpe AH
J Immunol; 2016 Oct; 197(8):3038-3048. PubMed ID: 27581174
[TBL] [Abstract][Full Text] [Related]
6. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
7. [Natalizumab: an antibody targeting α4-integrin].
Nakahara J
Brain Nerve; 2014 Oct; 66(10):1149-58. PubMed ID: 25296869
[TBL] [Abstract][Full Text] [Related]
8. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
[TBL] [Abstract][Full Text] [Related]
9. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
11. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Ramroodi N; Khani M; Ganjali Z; Javan MR; Sanadgol N; Khalseh R; Ravan H; Sanadgol E; Abdollahi M
Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats.
Miljković D; Stanojević Z; Momcilović M; Odoardi F; Flügel A; Mostarica-Stojković M
Immunobiology; 2011 Sep; 216(9):979-87. PubMed ID: 21601937
[TBL] [Abstract][Full Text] [Related]
14. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
von Kutzleben S; Pryce G; Giovannoni G; Baker D
Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice.
Papazian I; Kourouvani M; Dagkonaki A; Gouzouasis V; Dimitrakopoulou L; Markoglou N; Badounas F; Tselios T; Anagnostouli M; Probert L
Elife; 2024 Jun; 12():. PubMed ID: 38900149
[TBL] [Abstract][Full Text] [Related]
16. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
17. PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.
Selvaraj V; Soundarapandian MM; Chechneva O; Williams AJ; Sidorov MK; Soulika AM; Pleasure DE; Deng W
J Biol Chem; 2009 Sep; 284(38):26070-84. PubMed ID: 19628872
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Mokhtarian F; Safavi F; Sarafraz-Yazdi E
Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
[TBL] [Abstract][Full Text] [Related]
19. EGFL7 reduces CNS inflammation in mouse.
Larochelle C; Uphaus T; Broux B; Gowing E; Paterka M; Michel L; Dudvarski Stankovic N; Bicker F; Lemaître F; Prat A; Schmidt MHH; Zipp F
Nat Commun; 2018 Feb; 9(1):819. PubMed ID: 29483510
[TBL] [Abstract][Full Text] [Related]
20. Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.
Häusler D; Nessler S; Kruse N; Brück W; Metz I
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):814-31. PubMed ID: 25641089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
